110 KSA882Mu11 | 胃泌素抑制肽(GIP)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Mus musculus (Mouse,小鼠) USCN(武漢優爾生商貿有限公司)

真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

胃泌素抑制肽(GIP)檢測試劑盒DIY材料(酶聯免疫吸附試驗法)

ELISA Kit DIY Materials for Gastric Inhibitory Polypeptide (GIP)

Incretin hormone; Glucose Dependent Insulinotropic Peptide

  • 胃泌素抑制肽(GIP)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) 產品包裝(模擬)
  • 胃泌素抑制肽(GIP)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) 產品包裝(模擬)
  • Certificate 通過ISO 9001、ISO 13485質量體系認證

特異性

試劑盒中的抗體對胃泌素抑制肽(GIP)具有高靈敏度和高特異性,經檢測與其它相似物質無明顯交叉反應。

用法

1.用100μL每孔的工作濃度的包被抗體包被96孔板,4度孵育過夜或者37度孵育2小時;
2.洗板1次;
3.用200μL每孔的工作濃度的封閉液,37度孵育1.5小時;
4.洗板1次。酶標板即可用于ELISA實驗,后續使用方法與ELISA同。

儲存

抗體,標準品和HRP標記的鏈霉親和素在-20度保存,TMB需在4度保存,96孔板在室溫保存。所有組分保質期為1年,試劑一旦開封,在4度保存時間為1個月。

配套試劑

相關產品

編號 適用物種:Mus musculus (Mouse,小鼠) 應用(僅供研究使用,不用于臨床診斷!)
RPA882Mu02 胃泌素抑制肽(GIP)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA882Mu01 胃泌素抑制肽(GIP)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
CPA882Mu11 胃泌素抑制肽(GIP)牛血清白蛋白偶聯物 Immunogen; SDS-PAGE; WB.
CPA882Mu21 胃泌素抑制肽(GIP)卵白蛋白偶聯物 Immunogen; SDS-PAGE; WB.
PAA882Mu02 胃泌素抑制肽(GIP)多克隆抗體 WB; IHC; ICC; IP.
PAA882Mu08 胃泌素抑制肽(GIP)多克隆抗體 WB; IHC; ICC; IP.
PAA882Mu01 胃泌素抑制肽(GIP)多克隆抗體 WB; IHC; ICC; IP.
MEA882Mu 胃泌素抑制肽(GIP)檢測試劑盒(酶聯免疫吸附試驗法,小樣本) Enzyme-linked immunosorbent assay for Antigen Detection.
CEA882Mu 胃泌素抑制肽(GIP)檢測試劑盒(酶聯免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA882Mu 胃泌素抑制肽(GIP)等多因子檢測試劑盒(流式熒光發光法) FLIA Kit for Antigen Detection.
KSA882Mu11 胃泌素抑制肽(GIP)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) Main materials for "Do It (ELISA Kit) Yourself".

參考文獻

雜志 參考文獻
Scientific Reports The?anti-hyperglycemic?efficacy?of a?lipid-lowering?drug?Daming?capsule?and the?underlyingsignaling?mechanisms?in a?rat?model?of?diabetes?mellitus. [pubmed:27721485]
Obesity surgery The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats. [pubmed:28840471]
Obesity?Surgery? Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague?… [Pubmed:29098544]
BioMed Research International Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity []
Diabetes Research and Clinical Practice Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients [Pubmed: 31734225]
OBESITY SURGERY The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats [Pubmed: 31701411]
FUTURE SCIENCE Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes [Pubmed:35251693]
留言咨詢
永德县| 龙海市| 科技| 中卫市| 彭水| 金山区| 黄冈市| 华宁县| 德保县| 林州市| 潍坊市| 濉溪县| 太谷县| 娱乐| 广南县| 宁晋县| 南澳县| 临海市| 台湾省| 扶绥县| 辛集市| 长葛市| 嘉黎县| 丰城市| 亚东县| 凯里市| 霍州市| 兖州市| 泰兴市| 徐州市| 永州市| 营山县| 永宁县| 邢台县| 西藏| 家居| 江门市| 浑源县| 清流县| 天津市| 津市市|